[en] Antimicrobials’ topical administration efficacy has not been assessed in dogs with upper respiratory tract disease. The aim was to compare the concentration of gentamicin in nasal lavage fluid (NALF) and in serum after three topical protocols. This was a prospective crossover study of ten healthy dogs. Gentamicin was nebulized for a duration of 1 week, twice a day, for 10 min in the first protocol (10-min protocol) and for 3 min in the second protocol (3-min protocol), while the third protocol consisted of the administration of 0.25 mL of gentamicin in each nostril (drop protocol). Median concentrations of gentamicin in NALF were 9.39 µg/mL (8.12–19.97 interquartile range), 4.96 µg/mL (4.60–6.43) and 137.00 µg/mL (110.5–162.00) in the 10-min protocol, 3-min protocol and drop protocol, respectively. The result for the drop protocol was significantly higher than those of both nebulization protocols in NALF (p = 0.039). In serum, the gentamicin concentration was 0.98 µg/mL (0.65–1.53) and 0.25 µg/mL (0.25–0.44) in the 10-min and 3-min protocols, respectively. Gentamicin was not detected in the serum of seven out of ten dogs in the drop protocol, and gentamicin was significantly higher in the 10-min protocol compared to the drop protocol (p = 0.001). This study found that the 10-min, 3-min and drop protocols achieved superior concentrations in NALF compared to the minimum inhibitory concentration for gentamicin-sensitive bacteria, while remaining below the toxic values in blood.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Biénès, Tom; Department of Clinical Sciences, Faculty of Veterinary Medicine, B67 Sart Tilman, University of Liege, 4000 Liege, Belgium
Lyssens, Aurélie ; Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) > FARAH: Médecine vétérinaire comparée
Machiels, Hélène ; Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) > FARAH: Médecine vétérinaire comparée
Hercot, Marie-Eve ; Université de Liège - ULiège > Département d'Enseignement et de Clinique des animaux de Compagnie (DCC)
Fastrès, Aline ; Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) > FARAH: Médecine vétérinaire comparée
Alexandru-Cosmin, Tutunaru ; Department of Clinical Sciences, Faculty of Veterinary Medicine, B67 Sart Tilman, University of Liege, 4000 Liege, Belgium
Deville, Marine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de toxicologie clinique, médicolégale, environnementale et en entreprise
Charlier, Corinne ; Centre Hospitalier Universitaire de Liège - CHU > > Service de toxicologie clinique, médicolégale, environnementale et en entreprise
Billen, Frédéric ; Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) > FARAH: Médecine vétérinaire comparée
Clercx, Cécile ; Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) > FARAH: Médecine vétérinaire comparée
Language :
English
Title :
Intranasal and Serum Gentamicin Concentration: Comparison of Three Topical Administration Protocols in Dogs
Tasker S. Knottenbelt C.M. Munro E.A.C. Stonehewer J. Simpson J.W. Mackin A.J. Aetiology and diagnosis of persistent nasal disease in the dog: A retrospective study of 42 cases J. Small Anim. Pract. 1999 40 473 478 10.1111/j.1748-5827.1999.tb02998.x 10587924
Meler E. Dunn M. Lecuyer M. A retrospective study of canine persistent nasal disease: 80 cases (1998–2003) Can. Vet. J. 2008 49 71 76
Lobetti R.G. A retrospective study of chronic nasal disease in 75 dogs J. S. Afr. Vet. Assoc. 2009 80 224 228 10.4102/jsava.v80i4.212 20458862
Peeters D. Clercx C. Update on canine sinonasal aspergillosis Vet. Clin. N. Am. Small Anim. Pract. 2007 37 901 916 10.1016/j.cvsm.2007.05.005
Eloy J.A. Govindaraj S. Microbiology and Immunology of Rhinosinusitis Rhinosinusitis Thaler E. Kennedy D. Springer New York, NY, USA 2008 1 12
Chiu A.G. Osteitis in chronic rhinosinusitis Otolaryngol. Clin. N. Am. 2005 38 1237 1242 10.1016/j.otc.2005.07.007 16326181
Lee J.T. Kennedy D.W. Palmer J.N. Feldman M. Chiu A.G. The incidence of concurrent osteitis in patients with chronic rhinosinusitis: A clinicopathological study Am. J. Rhinol. 2006 20 278 282 10.2500/ajr.2006.20.2857
Kisiel M. Sjölander I. Klar A. Asplund Stenkvist M. Laurell G. Development of bacterial resistance during treatment with topical gentamicin for chronic rhinosinusitis in patients with cystic fibrosis and primary ciliary dyskinesis. Retrospective case series Otolaryngol. Pol. 2020 74 33 40 10.5604/01.3001.0013.7851
Nicolau D.P. Freeman C.D. Belliveau P.P. Nightingale C.H. Ross J.W. Quintiliani R. Experience with a once daily aminoglycoside program administered to 2184 adult patients Antimicrob. Agents Chemother. 1995 39 650 655 10.1128/AAC.39.3.650
Whatley W.S. Chandra R.K. MacDonald C.B. Systemic absorption of gentamicin nasal irrigations Am. J. Rhinol. 2006 20 251 254 10.2500/ajr.2006.20.2855
Belfield K. Bayston R. Birchall J.P. Daniel M. Do orally administered antibiotics reach concentrations in the middle ear sufficient to eradicate planktonic and biofilm bacteria? A review Int. J. Pediatr. Otorhinolaryngol. 2015 79 296 300 10.1016/j.ijporl.2015.01.003
Ebert S.C. Craig W.A. Pharmacodynamic properties of antibiotics: Application to drug monitoring and dosage regimen design Infect. Control Hosp. Epidemiol. 1990 11 319 326 10.1086/646178
Moore R.D. Lietman P.S. Smith C.R. Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration J. Infect. Dis. 1987 155 93 99 10.1093/infdis/155.1.93 3540140
Boisson M. Mimoz O. Hadzic M. Marchand S. Adier C. Couet W. Grégoire N. Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients J. Antimicrob. Chemother. 2018 73 2830 2837 10.1093/jac/dky239 29947799
Begg E.J. Peddie B.A. Chambers S.T. Boswell D.R. Comparison of gentamicin dosing regimens using an in-vitro model J. Antimicrob. Chemother. 1992 29 427 433 10.1093/jac/29.4.427
Skopnik H. Wallraf R. Nies B. Tröster K. Heimann G. Pharmacokinetics and antibacterial activity of daily gentamicin Arch. Dis. Child. 1992 67 57 61 10.1136/adc.67.1_Spec_No.57 1346956
Destache C.J. Aminoglycoside-induced nephrotoxicity—A focus on monitoring: A review of literature J. Pharm. Pract. 2014 27 562 566 10.1177/0897190014546102 25124375
Wei J.L. Sykes K.J. Johnson P. He J. Mayo M.S. Safety and efficacy of once-daily nasal irrigation for the treatment of pediatric chronic rhinosinusitis Laryngoscope 2011 121 1989 2000 10.1002/lary.21923 22024856
Bexfield N.H. Foale R.D. Davison L.J. Watson P.J. Skelly B.J. Herrtage M.E. Management of 13 cases of canine respiratory disease using inhaled corticosteroids J. Small Anim. Pract. 2006 47 377 382 10.1111/j.1748-5827.2006.00028.x
Morgane Canonne A. Roels E. Menard M. Desquilbet L. Billen F. Clercx C. Clinical response to 2 protocols of aerosolized gentamicin in 46 dogs with Bordetella bronchiseptica infection (2012–2018) J. Vet. Intern. Med. 2020 34 2078 2085 10.1111/jvim.15843
Erdő F. Bors L.A. Farkas D. Bajza Á. Gizurarson S. Evaluation of intranasal delivery route of drug administration for brain targeting Brain Res. Bull. 2018 143 155 170 10.1016/j.brainresbull.2018.10.009
López-Ramis V. Canfrán S. Gómez de Segura I.A. Comparison of the sedative effects of intranasal or intramuscular dexmedetomidine at low doses in healthy dogs: A randomized clinical trial Vet. Anaesth. Analg. 2022 49 572 579 10.1016/j.vaa.2022.08.003 36109295
Ellis J.A. Gow S.P. Lee L.B. Lacoste S. Ball E.C. Comparative efficacy of intranasal and injectable vaccines in stimulating Bordetella bronchiseptica-reactive anamnestic antibody responses in household dogs Can. Vet. J. 2017 58 809 815
Granstrand P. Nylander-French L. Holmstrom M. Biomarkers of nasal inflammation in wood-surface coating industry workers Am. J. Ind. Med. 1998 33 392 399 10.1002/(SICI)1097-0274(199804)33:4<392::AID-AJIM10>3.0.CO;2-U
Howarth P.H. Persson C.G. Meltzer E.O. Jacobson M.R. Durham S.R. Silkoff P.E. Objective monitoring of nasal airway inflammation in rhinitis J. Allergy Clin. Immunol. 2005 115 S414 S441 10.1016/j.jaci.2004.12.1134
Larsson B.M. Palmberg L. Malmberg P.O. Larsson K. Effect of exposure to swine dust on levels of IL-8 in airway lavage fluid Thorax 1997 52 638 642 10.1136/thx.52.7.638 9246137
Castano R. Thériault G. Maghni K. Ghezzo H. Malo J.L. Gautrin D. Reproducibility of nasal lavage in the context of the inhalation challenge investigation of occupational rhinitis Am. J. Rhinol. 2008 22 271 275 10.2500/ajr.2008.22.3165
Dubois N. Sqalli G. Gilson M. Charlier C. Analytical validation of a quantitative method for therapeutic drug monitoring on the Alinity®c Abbott Ann. Biol. Clin. 2020 78 147 155 10.1684/abc.2020.1535
Albarellos G. Montoya L. Ambros L. Multiple once-daily dose pharmacokinetics and renal safety of gentamicin in dogs J. Vet Pharmacol. Ther. 2004 27 21 25 10.1046/j.0140-7783.2003.00545.x
Rubinstein A. Intranasal administration of gentamicin in human subjects Antimicrob. Agents Chemother. 1983 23 778 779 10.1128/AAC.23.5.778
Kovalhuk L.C.S. Telles E.Q. Lima M.N. Rosario Filho N.A. Nasal lavage cytology and mucosal histopathological alterations in patients with rhinitis Braz. J. Otorhinolaryngol. 2020 86 434 442 10.1016/j.bjorl.2019.01.005 30846420
Scherzad A. Hagen R. Hackenberg S. Current Understanding of Nasal Epithelial Cell Mis-Differentiation J. Inflamm. Res. 2019 12 309 317 10.2147/JIR.S180853 31853193
Baughman R.P. Technical aspects of bronchoalveolar lavage: Recommendations for a standard procedure Semin. Respir. Crit. Care Med. 2007 28 475 485 10.1055/s-2007-991520 17975775
Rennard S.I. Basset G. Lecossier D. O’Donnell K.M. Pinkston P. Martin P.G. Crystal R.G. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution J. Appl. Physiol. 1986 60 532 538 10.1152/jappl.1986.60.2.532 3512509
Melamies M.A. Järvinen A.K. Seppälä K.M. Rita H.J. Rajamäki M.M. Comparison of results for weight-adjusted and fixed-amount bronchoalveolar lavage techniques in healthy Beagles Am. J. Vet. Res. 2011 72 694 698 10.2460/ajvr.72.5.694